Inotropic drugs for treatment of the failing heart.
D000628:Aminophylline / Q000627:therapeutic use; D000631:Aminopyridines / Q000627:therapeutic use; D000676:Amrinone; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002395:Catecholamines / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D020105:Milrinone; D009200:Myocardial Contraction / Q000187:drug effects*; D011728:Pyridones / Q000627:therapeutic use; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D013806:Theophylline / Q000627:therapeutic use
D000631:Aminopyridines; D002316:Cardiotonic Agents; D002395:Catecholamines; D004071:Digitalis Glycosides; D011728:Pyridones; D011943:Receptors, Adrenergic, beta; D000628:Aminophylline; D005934:Glucagon; D013806:Theophylline; D020105:Milrinone; D000676:Amrinone